Headlines
-
APC confirms KAPS to be replaced
Wednesday | Jul 31 2024THE Australian Pharmacy Council (APC) has announced a significant overhaul of its assessment process for overseas pharmacists.
-
Ramsay CEO shake-up
Wednesday | Jul 31 2024RAMSAY Health Care's long-serving Managing Director and Group CEO, Craig McNally, will retire at the end of Jun 2025, the company confirmed on ASX.
-
Fusion fix for workflows
Tuesday | Jul 30 2024A HUMAN-centred design in pharmacy will help unravel the tech integration challenges that many businesses face, according to pharmacist Marta Stybowski, Director of Fusion Health Space.
-
OA stem cell therapy relief in sight
Tuesday | Jul 30 2024NEW research by Australian biotechnology company Magellan Stem Cells shows promising therapeutic benefits of an off-the-shelf donor stem cell therapy for a debilitating knee joint disease.
-
Reflux relief guidelines
Tuesday | Jul 30 2024THE Australasian College of Pharmacy's new guidelines on the management of gastroesophageal reflux will provide evidence-based recommendations for community pharmacists on the assessment of reflux symptoms.
-
Vapes surrender starts
Monday | Jul 29 2024TO ALIGN with the new vaping regulations under the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024, the Federal Government has introduced transitional arrangements in Australia.
-
CDC announces winners for $20k promo
Monday | Jul 29 2024CHEMIST Discount Centre (CDC) has announced the four winners of its Save & Win promotion for Club Card loyalty customers for May and Jun, each of whom will receive a prize of $5,000.
-
Mayne pushes Sun Pharma
Friday | Jul 26 2024MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc.
-
Unscripted alcohol debate
Friday | Jul 26 2024PHARMACY Connect 2024 conference will feature a provocative 'Great Debate' during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
-
LTR secures millions in capital raise
Thursday | Jul 25 2024LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
